A cancer pill that costs nearly $900 in the United States is reportedly available in India for as little as ₹35. A viral video by an American woman living in India has now sparked a global debate over drug pricing.
Liz, an American currently residing in India, shared on social media that her mother-in-law is being treated for blood cancer with the drug Revlimid. According to her, a single tablet of the branded medicine costs around 900 dollars in the U.S.
She was surprised to discover that a generic version of the same medicine is available in India for ₹35 to ₹300, depending on the manufacturer. Calling the price difference shocking, Liz said, "We're being ripped off in America."
The video has attracted millions of views and reignited discussions about global pharmaceutical pricing, health insurance systems, and access to affordable medicines.
Experts say branded medicines in the U.S. are often expensive due to patent protections, regulatory costs, and market dynamics. In contrast, India is one of the world's largest producers of generic medicines, making many life-saving drugs significantly more affordable.
The viral video has once again highlighted the stark differences in healthcare costs and raised broader questions about access to essential medicines around the world.
